Paper3685979
Tumor cell rejection through terminal cell differentiation.
Jimenez JJ and 1 other. Science, 1987. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Tumor cell rejection through terminal cell differentiation. Papers, record 3685979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3685979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft Rejection | Major topic |
| Leukemia, Experimental | Major topic |
| Animals | |
| Animals, Newborn | |
| Cell Differentiation | |
| Cell Division | |
| Cell Line | |
| Cell Survival | |
| Neoplasm Transplantation | |
| Phagocytosis | |
| Rats |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AM 07114 | NIADDK NIH HHS | United States | PubMed |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37597697 | Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. | Bioorg Med Chem Lett | 2023 | https://conductscience.org/library/papers/37597697 | PubMed |
| 30691081 | The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression. | Med Sci (Basel) | 2019 | https://conductscience.org/library/papers/30691081 | PubMed |
| 29018329 | CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells. | Front Mol Neurosci | 2017 | https://conductscience.org/library/papers/29018329 | PubMed |
| 22037943 | 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? | Cancer Metastasis Rev | 2011 | https://conductscience.org/library/papers/22037943 | PubMed |
| 21881028 | Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21881028 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3685979
GET https://conductscience.org/api/papers/v1/3685979/authors